DOI: 10.1093/jjco/hyag179 ISSN: 1465-3621

Early progression after immune checkpoint inhibition: aligning assessment with disease distribution

Murat Kiracı

Standardizing 90-day assessment and including early death as treatment failure could clarify whether disease distribution remains associated with early progression after immune checkpoint inhibition.

More from our Archive